Understand the Place of Rimegepant in Migraine Management
June 2024
Rimegepant (Nurtec ODT) for acute migraine TREATMENT in adults will hit pharmacy shelves.
Rimegepant is an oral “gepant” similar to ubrogepant (Ubrelvy).
They block receptors of calcitonin gene-related peptide (CGRP), a vasodilator and pain sensitizer that spikes during migraine attacks.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive